Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Severe Obstructive Sleep Apnea Doubles Risk of Heart Attack Death

XTALKS VITALS NEWS

Sleep Apnea

A recent study published in the American Heart Association’s (AHA) journal, Circulation, found that both moderate and severe forms of sleep apnea were associated with a higher risk of cardiovascular disease.

Share this!

February 9, 2017 | by Sarah Hand, M.Sc.

February is American Heart Month, and according to the National Healthy Sleep Awareness Project, leaving severe obstructive sleep apnea untreated raises an individual’s risk of suffering a fatal heart attack. In order to raise public awareness of this risk, the associations – in partnership with the American Academy of Sleep Medicine (AASM), the Centers for Disease Control and Prevention (CDC) and the Sleep Research Society (SRS) – are launching an ad campaign called “Sleep Apnea Hurts Hearts.”

A recent study published in the American Heart Association’s (AHA) journal, Circulation, found that both moderate and severe forms of sleep apnea were associated with a higher risk of cardiovascular disease. Treatment for sleep apnea often involves the use of a continuous positive airway pressure (CPAP) device.



“Obstructive sleep apnea is a dangerous disease that can severely damage your heart if left untreated,” said Dr. Ronald Chervin, president of the AASM and a spokesperson for the National Healthy Sleep Awareness Project. “With millions of sufferers remaining undiagnosed, it is critical to raise nationwide awareness about obstructive sleep apnea so that it can be treated with CPAP therapy, which can reduce the risk of cardiovascular death.”

In the context of the ad campaign, the word HEARTS is used as an acronym which names all of the negative health consequences of uncontrolled obstructive sleep apnea. The condition increases the risk of heart failure, elevated blood pressure, atrial fibrillation, resistant hypertension, type 2 diabetes and stroke.

“It is clear that untreated, severe obstructive sleep apnea may have a devastating impact on heart health,” said Dr. Janet B. Croft, senior chronic disease epidemiologist in CDC's Division of Population Health. “Anyone who has symptoms of sleep apnea such as loud snoring in addition to obesity and a heart problem or high blood pressure should discuss their risk for sleep apnea with their doctor.”

Obstructive sleep apnea is characterized by the collapse of the upper airway during sleep, and affects almost 30 million Americans. Obesity, high blood pressure, snoring and fatigue are all risk factors and warning signs of sleep apnea, according to the National Healthy Sleep Awareness Project.


Keywords: Sleep Apnea, Heart Attack, Heart Disease


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Lavazza Acquires Controlling Stake in Canada’s Kicking Horse Coffee

May 26, 2017 - Italian coffee company Lavazza, has secured an 80 percent equity stake in Canadian organic and fair-trade coffee company Kicking Horse Coffee, in a deal worth CAD$215 million.

Featured In: Food News


FDA First: Keytruda Approved for Cancer Treatment Based on Biomarker Alone

May 25, 2017 - For the first time, the FDA has approved a cancer treatment for solid tumors based on the presence of a biomarker, as opposed to specifying a tissue of origin.

Featured In: Biotech News


One Year of Medically Assisted Dying in Canada

May 25, 2017 - In June of 2016, the federal government of Canada passed legislation to legalize medically assisted dying.

Featured In: Life Science News


LEAVE A COMMENT
 
  
THE XTALKS VITALS INDUSTRY BLOG

Top 5 Most Impactful Tweets in Life Sciences During the Last Week

REGISTER FOR THESE WEBINARS

EU IVD Regulation: Top Five Changes for Medical Device Manufacturers to Consider


Thermal Processing Systems for the Food Industry: A Guide to Selecting Thermal Equipment and Technology


Rare Disease & Orphan Drug Development: Cost-Efficient Trial Design to Minimize Cash Burn


eTMF Workflows: Active eTMF to Improve the Quality of Clinical Trials


Copyright © 2016-2017 Honeycomb Worldwide Inc.